SecSonar.com

Aspire Biopharma Holdings, Inc. (ASBP)

Aspire Biopharma Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Aspire Biopharma Holdings, Inc. (ASBP) is a Biotechnology company based in US with a market capitalization of $627.6K. Free cash flow was negative at -$4.9M. This page tracks ASBP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2 employees · IPO Feb 20, 2025

Valuation

Valuation & price

$5.61 · as of May 17, 2026 · -99.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$703$354$5.17Jul 25Dec 25Jul 26Jul 7, 25$343.20Jul 9, 25$391.20Jul 11, 25$396.00Jul 15, 25$381.60Jul 17, 25$427.20Jul 21, 25$490.80Jul 23, 25$498.00Jul 25, 25$600.00Jul 29, 25$571.20Jul 31, 25$457.20Aug 4, 25$438.00Aug 6, 25$384.00Aug 11, 25$439.20Aug 13, 25$478.80Aug 15, 25$430.80Aug 19, 25$560.40Aug 21, 25$644.40Aug 25, 25$660.00Aug 27, 25$639.60Aug 29, 25$690.00Sep 3, 25$703.20Sep 5, 25$614.40Sep 9, 25$517.20Sep 11, 25$542.40Sep 16, 25$534.00Sep 18, 25$528.00Sep 22, 25$504.00Sep 24, 25$488.40Sep 26, 25$430.80Sep 30, 25$247.20Oct 2, 25$504.00Oct 6, 25$462.00Oct 8, 25$436.80Oct 10, 25$396.00Oct 14, 25$410.40Oct 16, 25$382.80Oct 21, 25$380.40Oct 23, 25$403.20Oct 27, 25$416.40Oct 29, 25$472.80Oct 31, 25$459.60Nov 4, 25$416.40Nov 6, 25$318.00Nov 10, 25$184.80Nov 12, 25$128.40Nov 14, 25$127.20Nov 18, 25$127.20Nov 20, 25$117.60Nov 25, 25$121.20Nov 28, 25$127.20Dec 2, 25$120.00Dec 4, 25$110.40Dec 8, 25$109.20Dec 10, 25$102.00Dec 12, 25$114.00Dec 16, 25$124.80Dec 18, 25$120.00Dec 22, 25$116.40Dec 24, 25$116.40Dec 29, 25$129.60Jan 2, 26$164.40Jan 6, 26$126.00Jan 8, 26$123.60Jan 12, 26$114.00Jan 14, 26$70.80Jan 16, 26$66.30Jan 21, 26$57.30Jan 23, 26$56.70Jan 27, 26$48.30Jan 29, 26$43.80Feb 2, 26$51.00Feb 4, 26$46.50Feb 9, 26$43.20Feb 11, 26$40.50Feb 13, 26$42.90Feb 18, 26$46.50Feb 20, 26$42.90Feb 24, 26$41.40Feb 26, 26$43.50Mar 2, 26$43.50Mar 4, 26$39.60Mar 6, 26$34.80Mar 10, 26$36.60Mar 12, 26$33.90Mar 17, 26$26.26Mar 19, 26$19.72Mar 23, 26$26.08Mar 25, 26$33.90Mar 27, 26$27.40Mar 31, 26$30.90Apr 2, 26$30.60Apr 7, 26$31.50Apr 9, 26$36.00Apr 13, 26$34.20Apr 15, 26$16.35Apr 17, 26$8.09Apr 22, 26$6.67Apr 24, 26$6.15Apr 28, 26$6.26Apr 30, 26$6.64May 4, 26$6.28May 6, 26$5.58May 8, 26$5.55May 12, 26$5.17May 14, 26$5.87May 18, 26$6.68May 20, 26$6.03May 22, 26$5.41May 28, 26$5.53Jun 1, 26$5.96Jun 3, 26$5.84Jun 5, 26$5.34Jun 9, 26$5.97Jun 11, 26$6.00Jun 15, 26$5.65Jun 17, 26$6.36Jun 22, 26$6.29Jun 24, 26$6.54Jun 26, 26$6.00Jul 2, 26$6.21
$4.6552-week range$708.00
Loading valuation history…

Fundamentals

Key fundamentals

$627.6K

Market cap

—

Revenue growth (YoY)

-1.9%

Gross margin

-$4.9M

Free cash flow (USD)

$380.9K

Net debt

116.7%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2021 → 2025

FY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$0.00FY 2025$6.2K
$0$6.2K

Free cash flow by year

2021 → 2025

FY 2021$-260.00FY 2022$-1.4MFY 2023$-653.1KFY 2024$-265.2KFY 2025$-4.9M
-$260-$4.9M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-20.57)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventStockholder Meeting ResultsJun 22, 2026Filing
  • 8-K eventAcquisition AnnouncedJun 12, 2026Filing
  • 8-K eventShareholder Meeting AdjournedJun 12, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventReverse Stock SplitMay 14, 2026Filing
  • 8-K eventPrivate Placement CompletedApr 20, 2026Filing
  • 8-K eventSecurities Offering CompletionApr 17, 2026Filing
  • 8-K eventAcquisition AnnouncedApr 16, 2026Filing
  • 8-K eventStockholder Meeting ResultsApr 16, 2026Filing
  • 8-K eventSecurities Purchase AgreementApr 16, 2026Filing

Questions

Frequently asked questions

What is Aspire Biopharma Holdings, Inc.'s market cap?

Aspire Biopharma Holdings, Inc. (ASBP) has a market capitalization of $627.6K.

What is ASBP's P/E ratio?

A meaningful P/E ratio is not available for ASBP — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did Aspire Biopharma Holdings, Inc. last report earnings?

ASBP last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying ASBP stock?

SEC Form 4 filings show no open-market insider buys at Aspire Biopharma Holdings, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

SCNI

Scinai Immunotherapeutics Ltd.

$604.8K

BDRX

Biodexa Pharmaceuticals Plc

$573.7K

SPRC

SciSparc Ltd.

$523.4K

VRAX

Virax Biolabs Group Limited

$769K

ONCO

Onconetix, Inc.

$400.8K

PPBT

Purple Biotech Ltd.

$396K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.